ORIGINAL STUDIES |
Bakulin I.G., Sushilova A.G., Zharkov A.V.
The efficacy of inclusion of chronic atrophic gastritis and Helicobacter pylori infection screening in health survey programs
|
8-16 |
Lagutina S.N., Chizhkov P.A., Zuykova A.A., Dobrynina I.S., Popov V.N.
Clinical and diagnostic importance of intestinal microbiota in the development of non-specific ulcerative colitis
|
17-21 |
Aryamkina O.L., Dobrynina I.Yu., Biek A.Yu., Saitov A.R., Tarasova L.V., Zapevalov A.V., Grishmanovsky P.V., Grishmanovskaya O.N.
Possibilities for diagnostics of non-alcoholic fatty liver disease in patients with metabolically associated comorbid pathology
|
22-31 |
Medvedev Yu.V., Bakulin I.G.
Clinical and laboratory methods for estimation the stage of fibrosis in case of chronic liver diseases
|
32-44 |
Girfanova L.G., Khlynova O.V.
Cholesterosis of the gallblader and clinical and diagnostical characteristics of patients with different body weight
|
46-54 |
Mazurov V.I., Sayganov S.A., Bashkinov R.A., Sapozhnikov K.V., Gaydukova I.Z., Tolkacheva D.G., Sableva N.A., Inamova O.V., Petrova M.S., Zinserling А.Yu.
Effect of urate-lowering therapy on the progression of chronic kidney disease in patients with osteoarthritis and asymptomatic hyperuricemia
|
56-71 |
Abysov A.S., Kichigin V.A., Savvateeva O.A.
COVID-19 pandemic and the state of kidney function
|
72-80 |
Mukhamadieva V.N., Shamsutdinova N.G., Abdulganieva D.I., Abdrakipov R.Z.,Mukhina R.G., Dyakova E.V., Sukhorukova E.V.
Peculiarities of COVID-19 clinical course in patients with various rheumatic diseases
|
81-88 |
Lila A.M., Strebkova E.A., Alekseeva L.I., Taskina E.A., Kashevarova N.G.
The use of Alflutop® in real clinical practice: Results of a multicenter prospective observational study
|
90-101 |
Dimitrieva O.V., Tarasova L.V., Babokin V.E., Trofimov N.A.
Laboratory markers for the risk of pulmonary embolism development in patients with malignant neoplasms
|
102-109 |
REVIEWS |
Abdulganieva D.I., Alekseeva A.A.
Use of systemic corticosteroids in therapy of intestinal inflammatory diseases (Literature review)
|
110-119 |
Fedorchenko Yu.L., Korneeva N.V., Martynyuk M.V., Tagryt I.V.
Diseases of the upper gastrointestinal tract in patients with diabetes mellitus (Literature review and own research)
|
120-129 |
Prikhodko V.A., Okovity S.V., Kulikov A.N.
Gliflozins in non-alcoholic fatty liver disease: Perspectives of use outside diabetes, cardiac and nephroprotection
|
130-141 |
Shestakova E.A., Lazareva A.A., Mazurina N.V., Komshilova K.A., Ershova E.V.
Telemedical technologies in the treatment of obesity as a way of interdisciplinary approach implementation
|
142-151 |
GUIDELINES FOR PRACTITIONERS |
Saifutdinov R.G., Mukhamadieva R.R., Dvoryankina T.V., Saifutdinov R.R., Trefilova Yu.S., Saifutdinova T.V.
Eosinophilic colitis: Differential diagnosis and own observation
|
152-159 |
Tarasova L.V., Kucherova N.Yu.
A case of atherotrombotic variant of ischemic stroke in Crohn’s disease patient
|
160-166 |
LECTURES & REPORTS |
Bakulina N.V., Savilova I.V., Lutaenko E.A., Tsurtsumia D.B.
Perspectives for the use of nanotechnologies in Helicobacter pylori eradication
|
168-175 |
Kostenko D.Yu.
The COPD exacerbations equation: What do we know about variables? (Literature review)
|
176-183 |
Guideline for practitioners |
Gazdanova A.A., Lenkova N.I., Ryazantseva O.V., Solovieva S.A.
SKIN Disorders in the pathology of the digestive organs and malabsorption syndrome in general medical practice
|
184-192 |
Leschenko I.V., Malyavin A.G., Zaitsev A.A., Esaulova N.A.
Acute bronchitis: Main accents
|
194-200 |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
Tarasova L.V., Tsyganova Yu.V.
Therapy of non-alcoholic liver steatosis as an important factor in the prevention of complications of non-alcoholic fatty liver disease
|
202-206 |
Tarzimanova A.I.
Impact of long-term antiarrhythmic therapy on the progression of atrial fibrillation from paroxysmal to permanent form
|
208-213 |
Kamchatnov P.R., Prikazchikov S.V., Osmaeva Z.Kh., Chugunov A.V.
Improving the effectiveness of rehabilitation treatment of a patient who has suffered an ischemic stroke
|
214-224 |
Mubarakshina O.A., Somova M.N., Batishchev G.A.
Pathogenetic approaches to combined pharmacotherapy of cough syndrome
|
226-233 |
Activities of RNMOT |
Digest of interregional scientific and practical events under the aegis or with the participation of RSMSIM (September 2023)
|
234-236 |